Literature DB >> 21623442

PNA-based artificial nucleases as antisense and anti-miRNA oligonucleotide agents.

M Gaglione1, G Milano, A Chambery, L Moggio, A Romanelli, A Messere.   

Abstract

Because of its interesting chemical, physical and biological properties, Peptide Nucleic Acid (PNA) has attracted major attention in molecular biology, for diagnostics purposes and development of biosensors. PNAs have become candidates for gene therapeutic drugs in ANTISENSE (AO) strategy with favorable in vivo biochemical properties. Recently, antisense PNA oligonucleotides have been described in anti-miRNA approach (AMO). We propose PNA-based nucleases as AO and AMO agents. We report the design, synthesis and characterization of two kinds of artificial nucleases composed of a PEG-PNA-PEG domain conjugated to HGG·Cu (A) and DETA (B) as well known cleavage sites. Qualitative (MALDI-TOF) and quantitative (HTS) assays were planned to study nuclease activity of constructs A and B on RNA-3'-FAM target sequence. The results have highlighted the best performance of nuclease B and the relevance of the PEG spacer, in particular for conjugate A, in terms of efficiency of the cleavage, suggesting that conjugates A and B also act as potential antisense and anti-miRNA agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623442     DOI: 10.1039/c1mb05131h

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  9 in total

1.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

2.  Sequence-specific RNA cleavage by PNA conjugates of the metal-free artificial ribonuclease tris(2-aminobenzimidazole).

Authors:  Friederike Danneberg; Alice Ghidini; Plamena Dogandzhiyski; Elisabeth Kalden; Roger Strömberg; Michael W Göbel
Journal:  Beilstein J Org Chem       Date:  2015-04-16       Impact factor: 2.883

3.  A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.

Authors:  Tathiana Azevedo de Andrade; Adriane Feijo Evangelista; Antonio Hugo Froes Campos; Wagner Augusto Poles; Natalia Morais Borges; Claudia Malheiros Coutinho Camillo; Fernando Augusto Soares; Jose Vassallo; Roberto Pinto Paes; Maria Claudia Zerbini; Cristovam Scapulatempo; Antonio Correa Alves; Ken H Young; Gisele Wally Braga Colleoni
Journal:  Oncotarget       Date:  2014-12-15

4.  A Trisbenzimidazole Phosphoramidite Building Block Enables High-Yielding Syntheses of RNA-Cleaving Oligonucleotide Conjugates.

Authors:  Felix Zellmann; Michael W Göbel
Journal:  Molecules       Date:  2020-04-16       Impact factor: 4.411

Review 5.  Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.

Authors:  Svetlana Miroshnichenko; Olga Patutina
Journal:  Front Pharmacol       Date:  2019-05-16       Impact factor: 5.988

6.  Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression.

Authors:  Felice Amato; Rossella Tomaiuolo; Fabrizia Nici; Nicola Borbone; Ausilia Elce; Bruno Catalanotti; Stefano D'Errico; Carmine Marco Morgillo; Giuseppe De Rosa; Laura Mayol; Gennaro Piccialli; Giorgia Oliviero; Giuseppe Castaldo
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

7.  Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold.

Authors:  Xing-Liang Zhao; Bi-Cheng Chen; Jin-Chao Han; Lai Wei; Xiao-Ben Pan
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

8.  Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H.

Authors:  O A Patutina; M A Bazhenov; S K Miroshnichenko; N L Mironova; D V Pyshnyi; V V Vlassov; M A Zenkova
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

9.  Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance.

Authors:  Olga Patutina; Daria Chiglintseva; Elena Bichenkova; Svetlana Gaponova; Nadezhda Mironova; Valentin Vlassov; Marina Zenkova
Journal:  Molecules       Date:  2020-05-25       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.